Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endotoxin challenge before Fluenz in healthy volunteers
2015-004023-31Phase 2Completed
- Sponsor
- Radboudumc
- Start
- Jan 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial in influenza comparing Placebo followed by Fluenz with Lipopolysaccharide followed by Fluenz (2 arms). Primary endpoint: CXCL-10 concentration in nasal wash. Started Jan 2016; status: completed.
02
Drugs
live attenuated influenza vaccinelipopolysaccharide endotoxin
03
Conditions
influenza
Beyond the preview
Go deeper on 2015-004023-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004023-31.